Bill
A 6857
Overview: Bill Number: A 6857, Title: Relates to the HTLV-1 and HTLV-2 viruses, Status: REFERRED TO HEALTH, Introduced: March 14, 2025Purpose and Intent: This bill aims to address
Overview: Bill Number: A 6857, Title: Relates to the HTLV-1 and HTLV-2 viruses, Status: REFERRED TO HEALTH, Introduced: March 14, 2025
Purpose and Intent: This bill aims to address the public health concerns surrounding the HTLV-1 and HTLV-2 viruses, which can lead to serious health conditions but are often underdiagnosed. The legislation seeks to improve awareness, testing, and treatment for these viral infections.
Key Provisions:
- Requires the state health department to develop and implement a public awareness campaign about HTLV-1 and HTLV-2 infections
- Mandates that healthcare providers offer HTLV-1 and HTLV-2 testing to all pregnant women during routine prenatal care
- Directs the health department to establish guidelines for the clinical management and treatment of HTLV-1 and HTLV-2 infections
Affected Parties and Impacts:
- The general public would benefit from increased awareness and education about HTLV-1 and HTLV-2 infections
- Pregnant women and their newborns would have improved access to testing and early intervention for these viral infections
- Healthcare providers would be required to incorporate HTLV-1 and HTLV-2 testing and treatment into their standard practices
Procedural and Timeline Considerations:
The bill has been referred to the Health Committee for further consideration. If passed, the state health department would need to develop and implement the required public awareness campaign, testing protocols, and clinical management guidelines within a specified timeframe to address this public health issue.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
